Bruker Corporation Provides Revenue Guidance for the Fourth Quarter and Fiscal Year 2021
The Company currently expects revenue for the full year 2021 of approximately $2.4 billion, including an approximate 2.2% favorable impact from currency translation, and approximate 0.4% favorable from mergers and acquisitions. This reflects estimated year-over-year organic revenue growth in a range of 8.4 9.2% for the fourth quarter of fiscal year 2021 and approximately 18.2% organic growth for the full fiscal year 2021, compared to fiscal year 2020.